
What a Revised Schedule M raises GMP standards in India, what has changed for manufacturers, and how large firms and MSMEs can prepare for Compliance and CDSCO inspections. Revised Schedule M is the biggest overhaul of manufacturing rules for Indian Pharma in two decades. It moves the industry from basic […]
Read MoreA practical guide to post-market surveillance obligations, adverse event reporting timelines, PSUR filings, and CDSCO enforcement trends under India’s PvPI framework. Getting a Drug approved in India is only half the journey. Post-market surveillance and Pharmacovigilance compliance under India’s PvPI framework continue for the entire lifecycle of the product, not […]
Read MoreWalk down any Cosmetics aisle and you will see claims like “clinically proven,” “dermatologist tested,” or “reduces fine lines in two weeks.” These claims sell products — but under the Cosmetics Rules, 2020, they also come with legal responsibility. Under Rule 36 of the Cosmetics Rules, 2020, a Cosmetic must […]
Read More
A practical comparison of CDSCO vs FDA vs EMA, explaining how each regulator’s Drug approval process differs and why one Drug needs separate approvals in India, the US and Europe. A Drug approved in the United States is not automatically approved in India or Europe. Comparing CDSCO vs FDA vs […]
Read More
A quick guide on Change Authorized Agent India requirements, the role of a CDSCO Authorized Agent, and how foreign manufacturers manage this transition. Yes, a foreign manufacturer can absolutely change its Authorized Agent India appointment whenever business needs, performance concerns, or compliance requirements make a switch necessary. The process is […]
Read More
Traditional Medical Device regulation assumes a fixed product: what’s approved is what ships, indefinitely, until a formal change is filed and reviewed. Adaptive AI and machine learning algorithms break that assumption by design — a model that continues learning after deployment is, in a meaningful sense, a different product than […]
Read MoreA quick guide on the Class A & B Medical Device manufacturing license — covering State FDA rules, Form MD-3/MD-5, fees, and timelines for manufacturers. Every manufacturer entering India’s device market must secure a Class A & B Medical Device manufacturing license before commercial production begins. This applies specifically to […]
“Cosmeceutical” is a popular marketing word. It suggests something more powerful than an ordinary Cosmetic — a product that treats skin condition, not just improves appearance. The problem is that Indian law does not recognize “Cosmeceutical” as a regulatory category at all. A product is either a Cosmetic or a […]
Companies developing Cosmetics with new or unusual active ingredients face a higher regulatory bar in India than those using well-established formulations. Understanding what “new” means under the Cosmetics Rules, 2020, and what needs to go into a safety dossier, can save months of delay at the approval stage. Step One: Find Out If Your Ingredient Is Actually […]